Multi-center Observational Study Relating to the Tolerance of ISENTRESS® + TRUVADA® Prescribed in Post-Exposure Prophylaxis of Persons Recently Subjected to the Risk of Transmission of an HIV Infection

Trial Profile

Multi-center Observational Study Relating to the Tolerance of ISENTRESS® + TRUVADA® Prescribed in Post-Exposure Prophylaxis of Persons Recently Subjected to the Risk of Transmission of an HIV Infection

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Raltegravir (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Feb 2017 Status changed from not yet recruiting to completed.
    • 05 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top